These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27071370)

  • 1. Clinical Usefulness of a Mobile Application for the Appropriate Selection of the Antiarrhythmic Device in Heart Failure.
    Curcio A; DE Rosa S; Sabatino J; DE Luca S; Bochicchio A; Polimeni A; Santarpia G; Ricci P; Indolfi C
    Pacing Clin Electrophysiol; 2016 Jul; 39(7):696-702. PubMed ID: 27071370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Device Histogram-Based Simple Predictor of Mortality Risk in ICD and CRT-D Patients: The Heart Rate Score.
    Wilkoff BL; Richards M; Sharma A; Wold N; Jones P; Perschbacher D; Olshansky B
    Pacing Clin Electrophysiol; 2017 Apr; 40(4):333-343. PubMed ID: 28156008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness of indications for device therapy among a broad range of physicians: a survey study.
    Hübinette C; Lund LH; Gadler F; Ståhlberg M
    Europace; 2014 Nov; 16(11):1580-6. PubMed ID: 24451291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.
    Landolina M; Curnis A; Morani G; Vado A; Ammendola E; D'onofrio A; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2015 Aug; 17(8):1251-8. PubMed ID: 25976906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
    Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
    Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
    J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates of upgrade of ICD recipients to CRT in clinical practice and the potential impact of the more liberal use of CRT at initial implant.
    Scott PA; Whittaker A; Zeb M; Watts E; Yue AM; Roberts PR; Morgan JM
    Pacing Clin Electrophysiol; 2012 Jan; 35(1):73-80. PubMed ID: 22054072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
    van der Heijden AC; Borleffs CJ; Buiten MS; Thijssen J; van Rees JB; Cannegieter SC; Schalij MJ; van Erven L
    Heart Rhythm; 2015 Jun; 12(6):1169-76. PubMed ID: 25749138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey.
    Tilz R; Boveda S; Deharo JC; Dobreanu D; Haugaa KH; Dagres N
    Europace; 2016 Jun; 18(6):945-9. PubMed ID: 27297231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
    Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
    Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
    Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Patients with Advanced Heart Failure Who Receive Device-Based Therapy for Primary Prevention of Sudden Cardiac Death: Insights from the Israeli ICD Registry.
    Suleiman M; Goldenberg I; Samniah N; Rosso R; Marai I; Pekar A; Khalameizer V; Militianu A; Glikson M
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):738-45. PubMed ID: 25754272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D.
    Sebag FA; Lellouche N; Chen Z; Tritar A; O'Neill MD; Gill J; Wright M; Leclercq C; Rinaldi CA
    J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1368-75. PubMed ID: 25066404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
    JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
    Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
    Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.